(Press Release | 2019-04-26 17:29:39) Vienna, Tuesday, April 23, 2019. Marinomed Biotech AG, a globally active biopharmaceutical company with headquarters in Vienna, has announced the successful completion of the pivotal Phase III study [
Read More ]